Dilution Isn’t An Option For This Profitable Under-Followed Penny Stock With Share Repurchase In Place [GeoWire Weekly No. 160]
Welcome to The GeoWire , your source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Featured Videos, and More. Please share this if you like today’s newsletter and comment with any feedback.
If you are new or this was shared with you, you can join our email list here.
For real time analysis of our coverage universe, including new high conviction ideas and additions to our model portfolios, if you are not already a premium subscriber, consider supporting our movement by becoming a premium member today. GeoInvesting, 16 years and counting!
Run to $1.00 model portfolio remains in focus
We’ve been discussing our Run to $1.00 (R21) Model Portfolio a lot lately. If you missed it, here are a few key stats featured in our October 20, 2024 article, Setting the Record Straight on Why We Do What We Do:
In that article, we mentioned that as of 10/20/2024, the R21 had achieved an average return of 45% over an 11-year span—not bad for a portfolio of stocks that microcap haters would paint as speculative, where some have gained thousands of percent and produced tens of millions of dollars, including Xpel, Inc. (NASDAQ:XPEL), Tss, Inc. (OTCQB:TSSI), and Zynex, Inc. (NASDAQ:ZYXI).
As luck would have it, last week, we conducted a Skull Session Fireside Chat with a company added to the R21 Model Portfolio earlier this year, which we believe is reaching a growth inflection point.
One of the most critical insights we gained from the chat was that the primary constraint on the impressive profitable growth seen over the past year (sales increased of 12.8% so far in first nine months of 2024 over the same period last year) is the company’s ability to increase inventory—not manpower or equipment—to accommodate the high demand for its services. Encouragingly, the company has no plans to raise dilutive capital or take on debt that could weigh it down.
Now that the company has achieved profitability, management just plans to keep growing and methodically reinvest profits back into the business, paving the way to meet demand by targeting new product segments and geographic markets that it has yet to penetrate.
What’s also attractive is that net margins are currently around 17%. Furthermore, substantial net operating loss carryforwards should help keep these margins healthy for years to come, allowing the company to generate additional cash to reinvest back into operations and inventory.
It remains to be seen if this stock will join Tss, Inc. (OTCQB:TSSI), California Nanotechnologies Cor (OOTC:CANOF) (CNO.V) and Innovative Food Holdings, Inc. (OTCQB:IVFH) as three other stocks in the R21 that rose above the one dollar mark this year. However, we are starting to get more comfortable with this possibility.
Below, please view the full Skull Session.
The Full Skull Session Fireside Chat is only visible to paid subscribers of GeoInvesting. To access our expanded coverage on This Stock & More, Subscribe below.
Please don’t forget to consider supporting GeoInvesting with a premium subscription if you enjoyed this content, and want to see more of it. Complete this short survey to let us know you’re engaged and interested.
200+ multibaggers and counting
GeoInvesting is a premier research platform for microcap investors, dedicated to uncovering high-potential stock ideas in undervalued companies across various sectors. With over 30 years of investing experience, GeoInvesting has covered more than 1,500 equities, providing often actionable proprietary research. The platform has been instrumental in identifying 200+ multibagger stocks, and offers investors exclusive access to over 600 management interview clips, allowing for deeper due diligence and understanding of the microcap stocks, many of which make it to market-beating premium Model Portfolios. Join the GeoInvesting community for the best stock research and microcap insights to help you stay ahead in the market. To learn more about our Premium Services, go here.. (https://geoinvesting.com/premium-research/)
The post Dilution Isn’t An Option For This Profitable Under-Followed Penny Stock With Share Repurchase In Place [GeoWire Weekly No. 160] appeared first on GeoInvesting.
Source: https://geoinvesting.com/dilution-isnt-an-option-for-this-profitable-under-followed-penny-stock-with-share-repurchase-in-place/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.